169 related articles for article (PubMed ID: 27393480)
1. In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.
Zheng L; Zhu L; Zhao M; Shi J; Li Y; Yu J; Jiang H; Wu J; Tong Y; Liu Y; Hu M; Lu L; Liu Z
AAPS J; 2016 Sep; 18(5):1289-1299. PubMed ID: 27393480
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP.
Ge S; Yin T; Xu B; Gao S; Hu M
Pharm Res; 2016 Mar; 33(3):590-602. PubMed ID: 26502886
[TBL] [Abstract][Full Text] [Related]
4. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
5. Kaempferol suppression of acute colitis is regulated by the efflux transporters BCRP and MRP2.
Liu Y; Lu Y; Li X; Zhang Z; Sun L; Wang Y; He Z; Liu Z; Zhu L; Fu L
Eur J Pharm Sci; 2022 Dec; 179():106303. PubMed ID: 36252521
[TBL] [Abstract][Full Text] [Related]
6. Interplay of Efflux Transporters with Glucuronidation and Its Impact on Subcellular Aglycone and Glucuronide Disposition: A Case Study with Kaempferol.
Li Y; Lu L; Wang L; Qu W; Liu W; Xie Y; Zheng H; Wang Y; Qi X; Hu M; Zhu L; Liu Z
Mol Pharm; 2018 Dec; 15(12):5602-5614. PubMed ID: 30376625
[TBL] [Abstract][Full Text] [Related]
7. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.
An G; Gallegos J; Morris ME
Drug Metab Dispos; 2011 Mar; 39(3):426-32. PubMed ID: 21139040
[TBL] [Abstract][Full Text] [Related]
8. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
9. Transport of trans-tiliroside (kaempferol-3-β-D-(6"-p-coumaroyl-glucopyranoside) and related flavonoids across Caco-2 cells, as a model of absorption and metabolism in the small intestine.
Luo Z; Morgan MR; Day AJ
Xenobiotica; 2015; 45(8):722-30. PubMed ID: 25761590
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.
Yang Z; Zhu W; Gao S; Yin T; Jiang W; Hu M
Drug Metab Dispos; 2012 Oct; 40(10):1883-93. PubMed ID: 22736306
[TBL] [Abstract][Full Text] [Related]
11. Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza.
Yu XY; Zhou ZW; Lin SG; Chen X; Yu XQ; Liang J; Duan W; Wen JY; Li XT; Zhou SF
Xenobiotica; 2007 Apr; 37(4):375-415. PubMed ID: 17455112
[TBL] [Abstract][Full Text] [Related]
12. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
Dahan A; Amidon GL
Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
[TBL] [Abstract][Full Text] [Related]
13. MK571 inhibits phase-2 conjugation of flavonols by Caco-2/TC7 cells, but does not specifically inhibit their apical efflux.
Barrington RD; Needs PW; Williamson G; Kroon PA
Biochem Pharmacol; 2015 Jun; 95(3):193-200. PubMed ID: 25801004
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine.
Zhu W; Xu H; Wang SW; Hu M
AAPS J; 2010 Dec; 12(4):525-36. PubMed ID: 20582579
[TBL] [Abstract][Full Text] [Related]
15. Sulfonation Disposition of Acacetin: In Vitro and in Vivo.
Zhang Q; Zhu L; Gong X; Ruan Y; Yu J; Jiang H; Wang Y; Qi X; Lu L; Liu Z
J Agric Food Chem; 2017 Jun; 65(24):4921-4931. PubMed ID: 28540728
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats.
Juan ME; González-Pons E; Planas JM
J Nutr; 2010 Mar; 140(3):489-95. PubMed ID: 20089784
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides.
Jiang H; Yu J; Zheng H; Chen J; Wu J; Qi X; Wang Y; Wang X; Hu M; Zhu L; Liu Z
Pharm Res; 2017 Jul; 34(7):1402-1415. PubMed ID: 28421306
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice.
Álvarez AI; Vallejo F; Barrera B; Merino G; Prieto JG; Tomás-Barberán F; Espín JC
Drug Metab Dispos; 2011 Nov; 39(11):2008-12. PubMed ID: 21828252
[TBL] [Abstract][Full Text] [Related]
19. Efflux transport is an important determinant of ethinylestradiol glucuronide and ethinylestradiol sulfate pharmacokinetics.
Zamek-Gliszczynski MJ; Day JS; Hillgren KM; Phillips DL
Drug Metab Dispos; 2011 Oct; 39(10):1794-800. PubMed ID: 21708882
[TBL] [Abstract][Full Text] [Related]
20. Polycyclic aromatic hydrocarbons in food--efflux of the conjugated biomarker 1-hydroxypyrene is mediated by Breast Cancer Resistance Protein (ABCG2) in human intestinal Caco-2 cells.
Hessel S; Lampen A; Seidel A
Food Chem Toxicol; 2013 Dec; 62():797-804. PubMed ID: 24140465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
